This study confirms that conversion of single tumor pathological biomarkers occurs continuously during the course of breast cancer progression, with loss of hormone receptors (ER and PR) most commonly observed when primary tumor cells migrate from the breast to other anatomical sites. Here, ESR1 is linked to neoplasm.